Compounded Semaglutide: Units, mg and Dosing Errors

The same syringe number can mean a different dose

Milligrams measure the amount of semaglutide; milliliters measure liquid volume; syringe units are markings used to measure volume on a particular syringe. A number of units is not a universal semaglutide dose. The concentration on the vial and the syringe supplied determine how the prescription is measured.

That distinction matters most when a refill looks familiar. A different concentration can make yesterday's syringe instruction wrong for today's vial. Do not carry an old unit number forward, copy someone else's chart or use a general online conversion to resolve uncertain instructions. Ask the dispensing pharmacist and prescriber to confirm the directions for the exact product in your hand.

What FDA's error reports describe

FDA's dosing-error alert describes patients drawing five to twenty times the intended amount from compounded semaglutide vials. It also describes clinicians making conversion errors. Some people required medical attention or hospitalization. In one reported case, difficulty getting clarification from a telemedicine provider led a patient to search online and take five times the intended dose¹.

Those reports do not tell us the percentage of patients who experience an error. They identify a preventable kind of confusion. The lesson is not that a patient must become better at mental arithmetic; it is that the prescriber, pharmacy, label and supplied syringe must give a clear, consistent instruction.

Experiences reported in the Food and Drug Administration alert include patients with vomiting, dehydration and fainting¹. That is different from a casual discussion about whether a mild side effect is expected. If you think an error occurred, get medical help promptly and tell the clinician what was prescribed, what was injected and when. Do not wait for an online forum to compare symptoms.

Read the label as a conversation starter

When a new shipment arrives, check the patient name, medicine name, pharmacy contact information, concentration and directions. Compare the written instructions with the prescription message and the supplied syringe. A conflict is a reason to stop and ask for clarification before injecting, even if one of the documents looks official.

Ask the pharmacist to state the prescribed dose and demonstrate the intended measurement using that syringe. A useful confirmation identifies the exact vial and prescription, rather than offering a generic chart. If a video is provided, verify that it shows the same product and device you received. Convenience does not make an example transferable.

This table explains terms; it does not calculate an injection. Your dose cannot be established from the table alone. The missing information is not a trivial detail to fill in from another person's experience.

A refill or pharmacy change needs a new check

Keep the previous instructions available for comparison, but do not assume they are still valid. Tell the pharmacist if the syringe size, concentration, vial appearance or directions changed. Ask whether the old written instructions should be discarded and which document is now authoritative. If the prescription increased, ask for a new demonstration of that dose.

A household routine can make familiar packaging easy to overlook. Choose a quiet moment to read the new shipment rather than sorting it while also managing dinner or school bags. If another adult helps, both people need the same current instructions. A sticky note with an unexplained number can survive long after the prescription changes.

Photographs of the label and supplied syringe may help a clinician understand what arrived, but sharing patient information publicly is unnecessary. Use the pharmacy's or clinic's appropriate communication channel. Save the confirmed directions with the medication record so they can be checked when a question arises later.

Product quality is another question

Correct measurement does not establish that a compounded product is FDA-approved or equivalent to an approved medicine. FDA states that compounded drugs do not undergo its premarket review for safety, effectiveness and quality; it recommends using them when a medical need cannot be met by an available approved product². Discuss that need with the clinician rather than treating lower price as the complete medical explanation.

An approved product and a compounded vial may have different devices and instructions. Even approved medicines require training specific to their presentation: the current Zepbound label directs patients receiving a changed presentation to obtain appropriate training and consult its instructions³. That is a useful reminder that experience with one injection system is not proof of competence with another.

Ask who compounded the medication, who dispensed it and who answers questions after delivery. The compounded-versus-brand discussion explains the wider distinction; the immediate question here is whether you can obtain clear help for the product already prescribed.

Storage and supplies belong in the written plan

Get storage, first-use dating and disposal instructions from the dispensing pharmacy, and check them against current FDA advice. FDA now advises discarding multidose compounded GLP-1 vials within 28 days of first use even if medication remains, and using a new sterile syringe and needle each time². A larger shipment is not permission to keep an opened vial indefinitely.

Write the opening date on the record you use for medication, rather than relying on memory. If a package arrives warm or damaged, contact the pharmacy before using it. Do not decide that a vial is safe based on color alone. Product identity, handling and measurement all need their own clear answers.

If you think you injected the wrong amount

Seek prompt medical advice for a suspected dosing error. Severe symptoms, fainting, inability to keep fluids down or a medical emergency require urgent evaluation. Keep the vial, label, syringe information and dosing timeline available for clinicians. Do not improvise a compensating dose or a new schedule. If treatment is interrupted, obtain a specific restart plan from the prescriber.

Once immediate care is addressed, ask the clinician or pharmacist how the error happened and obtain corrected written instructions before further use. FDA also encourages reporting medication errors through MedWatch². The goal is a system that makes the next injection unambiguous, with a reachable professional who can explain it.